| What can we learn from genetic studies of systemic lupus erythematosus? Implications of genetic heterogeneity among populations in SLE. | |
| | |
MedLine Citation:
|
PMID: 20947557 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Recent progress in genetics has expanded the number of the genes associated with SLE to more than 20 in the past 2 years. One might assign these candidate genetic factors into several pre-existing biological pathways: (i) innate immune response including TLR/interferon signaling pathways (IRF5, STAT4, TNFAIP3, and TREX1); (ii) adaptive immune response (HLA-DR, PTPN22, PDCD1, STAT4, LYN, BLK, and BANK1) including B, T cells, and antigen-presenting cells; and (iii) immune complex clearance mechanism (FCGRs, CRP, and ITGAM). In addition, there are also several genes and loci that could not be assigned into previous known pathways (KIAA1542, PXK, XKR6, ATG5, etc), providing possible novel mechanisms in SLE. It has also been evident that there are similarities and differences in SLE susceptibility loci across ethnic groups. Here we categorize the susceptible genes into four groups. The first group is the consistently associated genes with similar risk allele frequency between multiple ethnic populations such as STAT4, TNFAIP3, BANK1, and IRAK1/MECP2. The second group is the genes that are consistently associated but show marked difference in risk allele frequency (BLK, IRF5). The third group is the genes in which different risk variants exist within a gene or genetic loci (allelic heterogeneity) such as HLA-DR, FCGRs, and IRF5. The fourth group is the genes that show consistently discrepancy between populations such as PTPN22 and possibly ITGAM, PXK, and LYN (genetic heterogeneity). The possible explanations for differences of susceptible genetic factors between populations could be different genetic backgrounds, contribution of gene-gene or gene-environment interaction, and the relation between marker and causal variants. Therefore, efforts to identify ethnic-specific genetic factors or disease causing variants should be necessary for individualized therapy for SLE in future. |
| | |
Authors:
|
H-S Lee; S-C Bae |
Related Documents
:
|
22022287 - Mutations in a guanylate cyclase gcy-35/gcy-36 modify bardet-biedl syndrome-associated ... 16084127 - A rapid method for retrovirus-mediated identification of complementation groups in fanc... 20226777 - Association of gstt1, gstm1 and cyp1a1 polymorphisms with susceptibility to systemic lu... 23636667 - Prognostic value of telomere attrition in patients with aplastic anemia. 3561487 - Adaptive variation in environmental and genetic sex determination in a fish. 11841487 - Further polymorphism of the mica gene. |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't; Review |
Journal Detail:
|
Title: Lupus Volume: 19 ISSN: 1477-0962 ISO Abbreviation: Lupus Publication Date: 2010 Oct |
Date Detail:
|
Created Date: 2010-10-15 Completed Date: 2011-03-24 Revised Date: 2011-07-11 |
Medline Journal Info:
|
Nlm Unique ID: 9204265 Medline TA: Lupus Country: England |
Other Details:
|
Languages: eng Pagination: 1452-9 Citation Subset: IM |
Affiliation:
|
Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, Korea. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Gene Frequency Genetic Heterogeneity* Genetic Predisposition to Disease* Humans Lupus Erythematosus, Systemic / genetics* Polymorphism, Genetic* |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Cardiovascular co-morbidity in Asians with lupus: theoretical concern or clinical reality?
Next Document: Anticytokine therapy in systemic lupus erythematosus.